1. |
Jemal A, Bray F, Center MM, et al. Global cancer statistics[J]. CA Cancer J Clin, 2011, 61(2):69-90.
|
2. |
Yang L. Incidence and mortality of gastric cancer in China[J]. World J Gastroenterol, 2006, 12(1):17-20.
|
3. |
梁寒. 胃癌转移规律及防治策略[J]. 中国普外基础与临床杂志, 2012, 19(1):8-11.
|
4. |
Toback FG, Walsh-Reitz MM, Musch MW, et al. Peptide fragments of AMP-18, a novel secreted gastric antrum mucosal protein, are mitogenic and motogenic[J]. Am J Physiol Gastrointest Liver Physiol, 2003, 285(2):G344-G353.
|
5. |
杜建军, 窦科峰, 彭淑牖, 等. 胃癌相关分泌蛋白CA11与胃癌关系的研究[J]. 中华胃肠外科杂志, 2003, 6(3):187-190.
|
6. |
Shiozaki K, Nakamori S, Tsujie M, et al. Human stomach-specific gene, CA11, is down-regulated in gastric cancer[J]. Int J Oncol, 2001, 19(4):701-707.
|
7. |
Rippa E, La Monica G, Allocca R, et al. Overexpression of gastrokine 1 in gastric cancer cells induces Fas-mediated apoptosis[J]. J Cell Physiol, 2011, 226(10):2571-2578.
|
8. |
NCCN clinical practice guidelines in oncology gastric cancer (including cancer in the proximal 5 cm of the stomach)[EB/OL]. NCCN guidelines,http://www. nccn. org/professionals/physician_gls/pdf/gastric. pdf.
|
9. |
车晓波, 刘文忠. 幽门螺杆菌常用诊断方法的评价[J]. 中华消化杂志, 2002, 22(11):691-693.
|
10. |
Yoon JH, Song JH, Zhang C, et al. Inactivation of the gastrokine 1 gene in gastric adenomas and carcinomas[J]. J Pathol, 2011, 223(5):618-625.
|
11. |
Oien KA, McGregor F, Butler S, et al. Gastrokine 1 is abundantly and specifically expressed in superficial gastric epithelium, down-regulated in gastric carcinoma, and shows high evolutionary conservation[J]. J Pathol, 2004, 203(3):789-797.
|
12. |
陈美娅, 任建林, 潘金水. AMP-18, 一种新发现的胃黏膜保护因子[J]. 世界华人消化杂志, 2006, 14(8):805-809.
|
13. |
Martin TE, Powell CT, Wang Z, et al. A novel mitogenicprotein that is highly expressed in cells of the gastric antrum mucosa[J]. Am J Physiol Gastrointest Liver Physiol, 2003, 285(2):G332-G343.
|
14. |
Lacy ER, Morris GP, Cohen MM. Rapid repair of the surface epithelium in human gastric mucosa after acute superficial injury[J]. J Clin Gastroenterol, 1993, 17(Suppl 1):S125-S135.
|
15. |
Nardone G, Martin G, Rocco A, et al. Molecular expression of Gastrokine 1 in normal mucosa and in Helicobacter pylori-related preneoplastic and neoplastic gastric lesions[J]. Cancer Biol Ther, 2008, 7(12):1890-1895.
|
16. |
Gisbert JP. Helicobacter pylori-related diseases:dyspepsia, ulcers and gastric cancer[J]. Gastroenterol Hepatol, 2011, 34(Suppl 2):15-26.
|
17. |
张启瑜. 钱礼腹部外科学[M]. 北京:人民卫生出版社, 2006:157-161.
|
18. |
Weck MN, Gao L, Brenner H. Helicobacter pylori infection and chronic atrophic gastritis:associations according to severity of disease[J]. Epidemiology, 2009, 20(4):569-574.
|
19. |
Ohata H, Kitauchi S, Yoshimura N, et al. Progression of chronic atrophic gastritis associated with Helicobacter pylori infection increases risk of gastric cancer[J]. Int J Cancer, 2004, 109(1):138-143.
|
20. |
张永乐, 薛英威, 蓝秀文, 等. 肿瘤标记物CA19-9、CEA对胃癌转移和预后预测价值的分析[J]. 哈尔滨医科大学学报, 2010, 44(2):181-184, 188.
|
21. |
Ucar E, Semerci E, Ustun H, et al. Prognostic value of preoperative CEA, CA19-9, CA72-4, and AFP levels in gastric cancer[J]. Adv Ther, 2008, 25(10):1075-1084.
|
22. |
Moss SF, Lee JW, Sabo E, et al. Decreased expression ofgastrokine 1 and the trefoil factor interacting protein TFIZ1/GKN2 in gastric cancer:influence of tumor histology and relationship to prognosis[J]. Clin Cancer Res, 2008, 14(13):4161-4167.
|
23. |
Yan GR, Xu SH, Tan ZL, et al. Proteomics characterization of gastrokine 1-induced growth inhibition of gastric cancer cells[J]. Proteomics, 2011, 11(18):3657-3664.
|
24. |
Yoon JH, Kang YH, Choi YJ, et al. Gastrokine 1 functions as a tumor suppressor by inhibition of epithelial-mesenchymal transition in gastric cancers[J]. J Cancer Res Clin Oncol, 2011, 137(11):1697-1704.
|
25. |
Xing R, Li W, Cui J, et al. Gastrokine 1 induces senescence through p16/Rb pathway activation in gastric cancer cells[J]. Gut, 2012, 61(1):43-52.
|